ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2874

Pro-Inflammatory FcRL4+ Memory B Cells in Joints of RA Patients: Immunoglobulin Gene Characteristics and Antigen Specificity

Khaled Amara1, Lorraine Yeo2, Natalie Sippl1, Philip Titcombe1, Andrew Filer3, Karim Raza3, Dagmar Scheel-Toellner2 and Vivianne Malmström4, 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, SE-17176 Solna, Stockholm, Sweden., Stockholm, Sweden, 2Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK, Birmingham, United Kingdom, 3Rheumatology Research Group, MRC Centre for Immune Regulation, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, 4Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autoantibodies, B cell targeting, monoclonal antibodies and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:    Our recent findings identified a subset of pro-inflammatory memory B cells in the RA synovium characterized by the expression of the surface protein Fc receptor like 4 (FcRL4)1. FcRL4+ve B cells produce RANKL, and express high levels of TNF mRNA, indicating a destructive, pro-inflammatory role for this B cell subpopulation. It is however unclear how synovial FcRL4+ve B cells develop, whether they have undergone hypermutation in germinal centers and the nature of their relationship with FcRL4-ve B cells at the same site. The aim of this project was to investigate whether autoreactive features would accumulate in the FcRL4+ve subset by investigating the antigen-specificity and Ig gene characteristics of FcRL4 +ve versus -ve B cells from both synovial tissue and fluid of RA patients.  

Methods: Single FcRL4+ve and -ve memory B cells were sorted from synovial tissue (n=2) and synovial fluid (n=5) of patients with active RA. Their Ig variable region genes were sequenced and subsequently expressed to generate recombinant monoclonal antibodies. Antigen-specificities of the generated monoclonal antibodies were determined by ELISA. 

Results: In total, we have cloned and sequenced B cell receptors from 332 individual B-cells (171 from FcRL4+ and 160 from FcRL4- cells). The Ig gene sequence analyses demonstrated that the Ig repertoire was highly diverse with no major differences in the IGH and IGK or IGL gene segment usage or IGHCDR3 features between FcRL4+ and FcRL4- memory B cells. From the sequenced clones we have so far generated 38 recombinant monoclonal antibodies (from both FcRL4+ve and FcRL4–ve B cells) and determined their specificity for citrullinated candidate autoantigens. We found no difference in the frequency of autoreactive Ig in the FcRL4 +ve versus -ve cells. 13 antibodies reacted to citrullinated antigens (including α-enolase, fibrinogen, and vimentin) without recognizing the unmodified arginine control peptides.

Conclusion: We conclude that the FcRL4+ve and FcRL4-ve memory B cells, while functionally and phenotypically distinct, are both post-germinal center hypermutated B cell subsets with similar Ig gene features. We have not identified a clonal relationship, but overall both B cell receptor characteristics and antigen specificities suggest that the two B cell subpopulations may originate from similar immune responses differentiating into functionally distinct subsets.

1 Yeo L, Lom H, Juarez M, et al. Ann Rheum Dis (2014) doi:10.1136/annrheumdis-2013-204116


Disclosure:

K. Amara,
None;

L. Yeo,
None;

N. Sippl,
None;

P. Titcombe,
None;

A. Filer,
None;

K. Raza,
None;

D. Scheel-Toellner,
None;

V. Malmström,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pro-inflammatory-fcrl4-memory-b-cells-in-joints-of-ra-patients-immunoglobulin-gene-characteristics-and-antigen-specificity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology